Skip to content

Investigator

Swey-Shen Chen

AAIIT LLC · funded by NIAID

Companies
2

Resolved onto their grants.

Grants
2

Federal awards on file.

Non-dilutive funding
$642k

Summed across those awards.

First award
May 1, 2025

On this record.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

  • AAIIT LLC

    ImmunologyGrant-only

    Momentum in another area
  • AAIIT LLC

    ImmunologyGrant-only

    Momentum in another area

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R43

    Protein display drug ANDI reduces asthmatic airway hyperreactivity

    $321k

    May 1, 2025NIAIDAAIIT LLCNIH RePORTER · 11175827 (opens the source filing in a new tab)

  2. R43

    Protein display drug ANDI reduces asthmatic airway hyperreactivity

    $321k

    May 1, 2025NIAIDAAIIT LLCNIH RePORTER · 11326302 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources